Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online August 17, 2007
Diabetes Care 30:2951-2956, 2007
DOI: 10.2337/dc07-1042
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1042v1
30/11/2951    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertoni, A. G.
Right arrow Articles by Szklo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertoni, A. G.
Right arrow Articles by Szklo, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Research

Insulin Resistance, Metabolic Syndrome, and Subclinical Atherosclerosis

The Multi-Ethnic Study of Atherosclerosis (MESA)

Alain G. Bertoni, MD, MPH1, Nathan D. Wong, PHD2, Steven Shea, MD3, Shuangge Ma, PHD4, Kiang Liu, PHD5, Srikanthan Preethi, MBBS6, David R. Jacobs, Jr, PHD7, Colin Wu, PHD8, Mohammed F. Saad, MD, MRCP9 and Moyses Szklo, MD10

1 Department of Epidemiology and Prevention, Wake Forest University, Winston-Salem, North Carolina
2 Division of Cardiology, University of California, Irvine, California
3 Departments of Medicine and Epidemiology, Columbia University, New York, New York
4 Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut
5 Department of Preventive Medicine, Northwestern University, Evanston, Illinois
6 Division of Epidemiology and Preventative Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
7 Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota
8 National Heart, Lung, and Blood Institute, Bethesda, Maryland
9 Graduate Program in Public Health, State University of New York at Stonybrook, Stonybrook, New York
10 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

Address correspondence and reprint requests to Dr. Bertoni, Public Health Sciences, Medical Center Blvd., Winston-Salem, NC 27157. E-mail: abertoni{at}wfubmc.edu

OBJECTIVE—To investigate the association of insulin resistance and clinically defined metabolic syndrome (MetS) with subclinical atherosclerosis and examine whether these relationships vary by race/ethnicity or sex.

RESEARCH DESIGN AND METHODS—Subclinical atherosclerosis was assessed by coronary artery calcium (CAC) and carotid intima-medial thickness (IMT) in 5,810 participants without diabetes in the Multi-Ethnic Study of Atherosclerosis, a cohort of adults aged 45–84 years without prior cardiovascular disease (CVD). Fasting insulin and glucose were utilized to estimate insulin resistance by the homeostasis model assessment of insulin resistance (HOMA-IR) index, and the revised National Cholesterol Education Program definition of MetS was utilized. Multivariable linear or relative risk regression was used to analyze the association between HOMA-IR and subclinical atherosclerosis and assess its independence from MetS components.

RESULTS—HOMA-IR was associated with increased IMT after adjustment for demographics (age, site, and education), smoking, education, and LDL cholesterol in each ethnic group, except Hispanic subjects, and in both men and women. After further adjusting for nonglucose MetS components, HOMA-IR was not associated with increased IMT. Subjects in the highest quintile of HOMA-IR had an elevated prevalence of CAC in each ethnic group and both sexes, after adjustment for demographics, smoking, and LDL but not after further adjustment for nonglucose MetS components. Among those with detectable CAC, there was no significant relationship between HOMA-IR and the amount of CAC.

CONCLUSIONS—Although HOMA-IR was associated with increased subclinical atherosclerosis, the association was not independent of the risk factors that comprise MetS. Determination of HOMA-IR is unlikely to contribute to improved determination of risk of subclinical CVD.

Abbreviations: CAC, coronary artery calcium • CC, common carotid • CVD, cardiovascular disease • HOMA-IR, homeostasis model assessment of insulin resistance • IC, internal carotid • IMT, intima-medial thickness • MESA, Multi-Ethnic Study of Atherosclerosis • MetS, metabolic syndrome


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. Qasim, N. N. Mehta, M. G. Tadesse, M. L. Wolfe, T. Rhodes, C. Girman, and M. P. Reilly
Adipokines, insulin resistance, and coronary artery calcification.
J. Am. Coll. Cardiol., July 15, 2008; 52(3): 231 - 236.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.